 | • レポートコード：QYR2104Z3158 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、炎症性腸疾患（IBD）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（TNF阻害剤、アミノサリサイクレート、免疫調節剤、コルチコステロイド）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・炎症性腸疾患（IBD）治療の市場動向 ・企業の競争状況、市場シェア ・炎症性腸疾患（IBD）治療の種類別市場規模（TNF阻害剤、アミノサリサイクレート、免疫調節剤、コルチコステロイド） ・炎症性腸疾患（IBD）治療の用途別市場規模（病院薬局、小売薬局、オンライン薬局） ・炎症性腸疾患（IBD）治療の北米市場規模2016-2027（アメリカ、カナダ） ・炎症性腸疾患（IBD）治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・炎症性腸疾患（IBD）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・炎症性腸疾患（IBD）治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・炎症性腸疾患（IBD）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie、Pfizer、Takeda、Janssen Biotech, Inc. (Johnson & Johnson)、Allergan、Bausch Health、Takeda Pharmaceutical、Novartis、Biogen Inc.） ・結論 |
Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes the inflammation sores in the inner lining of colon and rectum. The Crohn’s disease affects any part of gastrointestinal tract and unlike ulcerative colitis, it affects all the layers of gastrointestinal walls. The ulcerative colitis is more prevalent than that of Crohn’s disease. The IBD affects equally in men and women and has prevalence and incidence rates in developed countries than that of developing and under developed countries. The exact cause of inflammatory bowel disease are not well understood however, the combination of several factors such as autoimmune disorders, genetic factors, lifestyle related risks factors such as smoking, sedentary lifestyle, lack of exercise are likely to contribute to the development of symptoms of inflammatory bowel disease. The common symptoms of inflammatory bowel disease includes the severe abdominal cramps and pain, persistent diarrhea, occasional rectal bleeding.
The IBD has no permanent cure and requires the lifelong disease management and treatment. Several medications such as corticosteroids, aminosalicyclates, immunomodulators, and biologic drugs such as TNF inhibitors and up to certain extent antibiotic drugs are prescribed to relive the symptoms of these diseases.
Market Analysis and Insights: Global Inflammatory Bowel Disease (IBD) Treatment Market
The global Inflammatory Bowel Disease (IBD) Treatment market size is projected to reach US$ 15660 million by 2026, from US$ 13310 million in 2019, at a CAGR of 2.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Inflammatory Bowel Disease (IBD) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Inflammatory Bowel Disease (IBD) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Inflammatory Bowel Disease (IBD) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Inflammatory Bowel Disease (IBD) Treatment market.
Global Inflammatory Bowel Disease (IBD) Treatment Scope and Market Size
Inflammatory Bowel Disease (IBD) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Inflammatory Bowel Disease (IBD) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
TNF Inhibitors
Aminosalicyclates
Immunomodulators
Corticosteroids
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AbbVie
Pfizer
Takeda
Janssen Biotech, Inc. (Johnson & Johnson)
Allergan
Bausch Health
Takeda Pharmaceutical
Novartis
Biogen Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 TNF Inhibitors
1.2.3 Aminosalicyclates
1.2.4 Immunomodulators
1.2.5 Corticosteroids
1.3 Market by Application
1.3.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Perspective (2016-2027)
2.2 Inflammatory Bowel Disease (IBD) Treatment Growth Trends by Regions
2.2.1 Inflammatory Bowel Disease (IBD) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Inflammatory Bowel Disease (IBD) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Inflammatory Bowel Disease (IBD) Treatment Industry Dynamic
2.3.1 Inflammatory Bowel Disease (IBD) Treatment Market Trends
2.3.2 Inflammatory Bowel Disease (IBD) Treatment Market Drivers
2.3.3 Inflammatory Bowel Disease (IBD) Treatment Market Challenges
2.3.4 Inflammatory Bowel Disease (IBD) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Inflammatory Bowel Disease (IBD) Treatment Players by Revenue
3.1.1 Global Top Inflammatory Bowel Disease (IBD) Treatment Players by Revenue (2016-2021)
3.1.2 Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Inflammatory Bowel Disease (IBD) Treatment Revenue
3.4 Global Inflammatory Bowel Disease (IBD) Treatment Market Concentration Ratio
3.4.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease (IBD) Treatment Revenue in 2020
3.5 Inflammatory Bowel Disease (IBD) Treatment Key Players Head office and Area Served
3.6 Key Players Inflammatory Bowel Disease (IBD) Treatment Product Solution and Service
3.7 Date of Enter into Inflammatory Bowel Disease (IBD) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Inflammatory Bowel Disease (IBD) Treatment Breakdown Data by Type
4.1 Global Inflammatory Bowel Disease (IBD) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Type (2022-2027)
5 Inflammatory Bowel Disease (IBD) Treatment Breakdown Data by Application
5.1 Global Inflammatory Bowel Disease (IBD) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Inflammatory Bowel Disease (IBD) Treatment Market Size (2016-2027)
6.2 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type
6.2.1 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2016-2021)
6.2.2 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2022-2027)
6.2.3 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2016-2027)
6.3 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application
6.3.1 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2016-2021)
6.3.2 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2022-2027)
6.3.3 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2016-2027)
6.4 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country
6.4.1 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2016-2021)
6.4.2 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size (2016-2027)
7.2 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Type
7.2.1 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2016-2027)
7.3 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Application
7.3.1 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2016-2027)
7.4 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Country
7.4.1 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Type
8.2.1 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Application
8.3.1 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Region
8.4.1 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size (2016-2027)
9.2 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type
9.2.1 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2016-2027)
9.3 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application
9.3.1 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2016-2027)
9.4 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country
9.4.1 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Type
10.2.1 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Application
10.3.1 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Country
10.4.1 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Inflammatory Bowel Disease (IBD) Treatment Introduction
11.1.4 AbbVie Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Inflammatory Bowel Disease (IBD) Treatment Introduction
11.2.4 Pfizer Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Takeda Business Overview
11.3.3 Takeda Inflammatory Bowel Disease (IBD) Treatment Introduction
11.3.4 Takeda Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021)
11.3.5 Takeda Recent Development
11.4 Janssen Biotech, Inc. (Johnson & Johnson)
11.4.1 Janssen Biotech, Inc. (Johnson & Johnson) Company Details
11.4.2 Janssen Biotech, Inc. (Johnson & Johnson) Business Overview
11.4.3 Janssen Biotech, Inc. (Johnson & Johnson) Inflammatory Bowel Disease (IBD) Treatment Introduction
11.4.4 Janssen Biotech, Inc. (Johnson & Johnson) Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021)
11.4.5 Janssen Biotech, Inc. (Johnson & Johnson) Recent Development
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Inflammatory Bowel Disease (IBD) Treatment Introduction
11.5.4 Allergan Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021)
11.5.5 Allergan Recent Development
11.6 Bausch Health
11.6.1 Bausch Health Company Details
11.6.2 Bausch Health Business Overview
11.6.3 Bausch Health Inflammatory Bowel Disease (IBD) Treatment Introduction
11.6.4 Bausch Health Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021)
11.6.5 Bausch Health Recent Development
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Details
11.7.2 Takeda Pharmaceutical Business Overview
11.7.3 Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Introduction
11.7.4 Takeda Pharmaceutical Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021)
11.7.5 Takeda Pharmaceutical Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Inflammatory Bowel Disease (IBD) Treatment Introduction
11.8.4 Novartis Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 Biogen Inc.
11.9.1 Biogen Inc. Company Details
11.9.2 Biogen Inc. Business Overview
11.9.3 Biogen Inc. Inflammatory Bowel Disease (IBD) Treatment Introduction
11.9.4 Biogen Inc. Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021)
11.9.5 Biogen Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Inflammatory Bowel Disease (IBD) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of TNF Inhibitors
Table 3. Key Players of Aminosalicyclates
Table 4. Key Players of Immunomodulators
Table 5. Key Players of Corticosteroids
Table 6. Global Inflammatory Bowel Disease (IBD) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Regions (2016-2021)
Table 10. Global Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Regions (2022-2027)
Table 12. Inflammatory Bowel Disease (IBD) Treatment Market Trends
Table 13. Inflammatory Bowel Disease (IBD) Treatment Market Drivers
Table 14. Inflammatory Bowel Disease (IBD) Treatment Market Challenges
Table 15. Inflammatory Bowel Disease (IBD) Treatment Market Restraints
Table 16. Global Inflammatory Bowel Disease (IBD) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Players (2016-2021)
Table 18. Global Top Inflammatory Bowel Disease (IBD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Bowel Disease (IBD) Treatment as of 2020)
Table 19. Ranking of Global Top Inflammatory Bowel Disease (IBD) Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Inflammatory Bowel Disease (IBD) Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Inflammatory Bowel Disease (IBD) Treatment Product Solution and Service
Table 23. Date of Enter into Inflammatory Bowel Disease (IBD) Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Inflammatory Bowel Disease (IBD) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. AbbVie Company Details
Table 64. AbbVie Business Overview
Table 65. AbbVie Inflammatory Bowel Disease (IBD) Treatment Product
Table 66. AbbVie Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021) & (US$ Million)
Table 67. AbbVie Recent Development
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Inflammatory Bowel Disease (IBD) Treatment Product
Table 71. Pfizer Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Takeda Company Details
Table 74. Takeda Business Overview
Table 75. Takeda Inflammatory Bowel Disease (IBD) Treatment Product
Table 76. Takeda Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021) & (US$ Million)
Table 77. Takeda Recent Development
Table 78. Janssen Biotech, Inc. (Johnson & Johnson) Company Details
Table 79. Janssen Biotech, Inc. (Johnson & Johnson) Business Overview
Table 80. Janssen Biotech, Inc. (Johnson & Johnson) Inflammatory Bowel Disease (IBD) Treatment Product
Table 81. Janssen Biotech, Inc. (Johnson & Johnson) Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021) & (US$ Million)
Table 82. Janssen Biotech, Inc. (Johnson & Johnson) Recent Development
Table 83. Allergan Company Details
Table 84. Allergan Business Overview
Table 85. Allergan Inflammatory Bowel Disease (IBD) Treatment Product
Table 86. Allergan Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021) & (US$ Million)
Table 87. Allergan Recent Development
Table 88. Bausch Health Company Details
Table 89. Bausch Health Business Overview
Table 90. Bausch Health Inflammatory Bowel Disease (IBD) Treatment Product
Table 91. Bausch Health Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021) & (US$ Million)
Table 92. Bausch Health Recent Development
Table 93. Takeda Pharmaceutical Company Details
Table 94. Takeda Pharmaceutical Business Overview
Table 95. Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Product
Table 96. Takeda Pharmaceutical Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021) & (US$ Million)
Table 97. Takeda Pharmaceutical Recent Development
Table 98. Novartis Company Details
Table 99. Novartis Business Overview
Table 100. Novartis Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021) & (US$ Million)
Table 101. Novartis Recent Development
Table 102. Biogen Inc. Company Details
Table 103. Biogen Inc. Business Overview
Table 104. Biogen Inc. Inflammatory Bowel Disease (IBD) Treatment Product
Table 105. Biogen Inc. Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021) & (US$ Million)
Table 106. Biogen Inc. Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Type: 2020 VS 2027
Figure 2. TNF Inhibitors Features
Figure 3. Aminosalicyclates Features
Figure 4. Immunomodulators Features
Figure 5. Corticosteroids Features
Figure 6. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Online Pharmacy Case Studies
Figure 10. Inflammatory Bowel Disease (IBD) Treatment Report Years Considered
Figure 11. Global Inflammatory Bowel Disease (IBD) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Inflammatory Bowel Disease (IBD) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Regions (2022-2027)
Figure 15. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Players in 2020
Figure 16. Global Top Inflammatory Bowel Disease (IBD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Bowel Disease (IBD) Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Inflammatory Bowel Disease (IBD) Treatment Revenue in 2020
Figure 18. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Inflammatory Bowel Disease (IBD) Treatment Market Share by Type (2016-2027)
Figure 22. North America Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2016-2027)
Figure 23. North America Inflammatory Bowel Disease (IBD) Treatment Market Share by Country (2016-2027)
Figure 24. United States Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Inflammatory Bowel Disease (IBD) Treatment Market Share by Type (2016-2027)
Figure 28. Europe Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2016-2027)
Figure 29. Europe Inflammatory Bowel Disease (IBD) Treatment Market Share by Country (2016-2027)
Figure 30. Germany Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Share by Region (2016-2027)
Figure 40. China Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AbbVie Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021)
Figure 61. Takeda Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021)
Figure 62. Janssen Biotech, Inc. (Johnson & Johnson) Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021)
Figure 63. Allergan Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021)
Figure 64. Bausch Health Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021)
Figure 65. Takeda Pharmaceutical Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021)
Figure 67. Biogen Inc. Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の炎症性腸疾患治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Inflammatory Bowel Disease Treatment Market The global Inflammatory Bowel Disease Treatment market size is projected to reach US$ 15660 million by 2026, from US$ 13310 million in 2019, at a CAGR of 2.3% during 2021-2026. With industry-standard accuracy in analysi…- 世界の炎症性腸疾患治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Inflammatory Bowel Disease Therapeutics Market The global Inflammatory Bowel Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…
- 世界の炎症性腸疾患緩和市場規模・現状・予測（2021年-2027年） Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative disease (UC), are proposed to result from an inappropriate immune response to the gut microbes in a genetically susceptible host. Market Analysis and Insights: Global Inflammatory Bowel Disease Relief Market The global …
- 世界の炎症性腸疾患市場規模・現状・予測（2021年-2027年） Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis are the principal types of inflammatory bowel disease. Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stom…
- 世界の炎症性腸疾患治療薬市場 2021：企業別、地域別、種類・用途別 The Inflammatory Bowel Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…